Patents by Inventor Kwon Moo PARK

Kwon Moo PARK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition comprising oleanolic acid acetate as active ingredient for preventing, alleviating, or treating renal toxicity induced by medicine
    Patent number: 11464787
    Abstract: The present invention relates to a composition for preventing, improving or treating drug-induced nephrotoxicity, the composition comprising oleanolic acid acetate as an active ingredient. More specifically, the present invention relates to a pharmaceutical composition for preventing or treating drug-induced nephrotoxicity comprising oleanolic acid acetate or a pharmaceutically acceptable salt thereof as an active ingredient, a health functional food for preventing or improving drug-induced nephrotoxicity comprising the active ingredients, and an anticancer adjuvant comprising the active ingredients. The oleanolic acid acetate of the present invention is derived from a natural product and has no side effects and no cytotoxicity and has excellent effects of preventing, improving and treating nephrotoxicity caused by a drug, particularly a platinum-based anticancer drug, so that it can be utilized as a pharmaceutical composition, a health functional food, and a cancer adjuvant thereof.
    Type: Grant
    Filed: September 29, 2017
    Date of Patent: October 11, 2022
    Assignee: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
    Inventors: Mun Chual Rho, Seung Woong Lee, Soyoung Lee, Sang-Hyun Kim, Kwon Moo Park, Woo Song Lee, Kyungsook Jung, Chan Sun Park
  • COMPOSITION COMPRISING OLEANOLIC ACID ACETATE AS ACTIVE INGREDIENT FOR PREVENTING, ALLEVIATING, OR TREATING RENAL TOXICITY INDUCED BY MEDICINE
    Publication number: 20200046728
    Abstract: The present invention relates to a composition for preventing, improving or treating drug-induced nephrotoxicity, the composition comprising oleanolic acid acetate as an active ingredient. More specifically, the present invention relates to a pharmaceutical composition for preventing or treating drug-induced nephrotoxicity comprising oleanolic acid acetate or a pharmaceutically acceptable salt thereof as an active ingredient, a health functional food for preventing or improving drug-induced nephrotoxicity comprising the active ingredients, and an anticancer adjuvant comprising the active ingredients. The oleanolic acid acetate of the present invention is derived from a natural product and has no side effects and no cytotoxicity and has excellent effects of preventing, improving and treating nephrotoxicity caused by a drug, particularly a platinum-based anticancer drug, so that it can be utilized as a pharmaceutical composition, a health functional food, and a cancer adjuvant thereof.
    Type: Application
    Filed: September 29, 2017
    Publication date: February 13, 2020
    Applicant: Korea Research Institute of Bioscience and Biotechnology
    Inventors: Mun Chual RHO, Seung Woong LEE, Soyoung LEE, Sang-Hyun KIM, Kwon Moo PARK, Woo Song LEE, Kyungsook JUNG, Chan Sun PARK